Cadila Healthcare has posted a 67.7% YoY increase in consolidated net profit, at Rs.543.3 crore. Profit for the corresponding quarter, last year was at Rs.323.9 crore.

Consolidated revenue from operations increased by 41% to Rs.3,259.6 crore for the quarter ended December 2017, as against Rs.2,311.1 crore in the year ago quarter. Operating profit for the quarter increased 99.9% to Rs.841.2 crore and margin expanded by 770 basis points to 25.8% compared to year-ago.

Tax expenses for the quarter was at Rs.178.6 crore, as against Rs.8.1 crore in the corresponding period, last year. Furthermore, the company during the quarter under review, has also received approval for 24 new products for the US market and has filed 10 additional abbreviated new drug applications (ANDAs) with the USFDA.

Read EquityPandit’s Technical Analysis of Nifty Pharma Outlook for the Week